SVS.H — Solarvest Bioenergy Income Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
Annual income statement for Solarvest Bioenergy, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.01 | 0.002 | 0.001 | 0.001 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | 0 | -0 | 0.001 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.5 | 2.5 | 1.63 | 1.89 | 0.878 |
| Operating Profit | -1.49 | -2.5 | -1.63 | -1.89 | -0.878 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.54 | -3.46 | -1.63 | -2.41 | -0.801 |
| Net Income After Taxes | -1.54 | -3.46 | -1.63 | -2.41 | -0.801 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.54 | -3.46 | -1.63 | -2.41 | -0.801 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.54 | -3.46 | -1.63 | -2.41 | -0.801 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.038 | -0.078 | -0.029 | -0.04 | -0.015 |